Topical composition for treating pain

Patent metadata

Field	Value
Publication number	US-9511016-B2
Application number	US-85124107-A
Country	US
Kind code	B2
Filing date	Sep 6, 2007
Priority date	Jun 12, 2007
Publication date	Dec 6, 2016
Grant date	Dec 6, 2016

Abstract

Topical compositions having as the active ingredient a lipid, fatty acid ester, natural wax, sterol, or combinations thereof referred to herein as “lipophilic vehicle” or “LV” and methods of use, have been developed for the amelioration or prevention of pain or the sequelae of pain. The composition may be in the form of an ointment, cream, gel, lotion, spray, foam, paste, patch, suspension or dispersion. The composition is variably effective to treat visceral, somatic and neuropathic pain both acute and chronic as well as muscle pain and stiffness and joint pain and stiffness.

First claim

We claim:

1. A method for the treatment of pain in a subject, wherein the pain is selected from the group consisting of joint pain, surface somatic pain, and pain associated with an inflammatory arthropathy, bursitis, a tendinopathy, psoriasis, or muscle stiffness, the method consisting of:
(a) topically administering to the skin, at or adjacent to the site in need of treatment for pain, an effective amount of a formulation consisting of:
i) an active ingredient, as the only pain relieving active ingredient in the formulation, selected from the group consisting of lecithin, isopropyl palmitate, isopropyl myristate, and combinations thereof; and
ii) an aqueous mixture of excipients to form a cream, gel, lotion, paste, suspension or dispersion, for topical application to the skin of the subject; to thereby alleviate pain in the subject, said excipients being one or more of:
(a) cetyl alcohol,
(b) stearyl alcohol,
(c) glycerin monostearate,
(d) stearic acid,
(e) polyoxyl 40 stearate,
(f) urea,
(g) imidurea,
(h) alkanols,
(i) preservatives,
(j) buffers, and
(k) collodial insoluble skin protectant;
wherein the formulation does not contain a pain relieving ingredient other than said active ingredient; and

(b) optionally administering to the subject one or more additional therapies selected from the group consisting of iontophoresis, transcutaneous electrical nerve stimulation (TENS), muscle stimulation, diathermy, radiation therapy, infrared, ultraviolet and cold laser.

2. The method of claim 1 , wherein the pain is joint pain.

3. The method of claim 1 , further consisting of administering to the subject one or more additional therapies selected from the group consisting of iontophoresis, transcutaneous electrical nerve stimulation (TENS), muscle stimulation, diathermy, radiation therapy, infrared, ultraviolet and cold laser.

4. The method of claim 1 , wherein the active ingredient is a combination of lecithin, isopropyl palmitate, and isopropyl myristate.

5. The method of claim 1 , wherein the active ingredient is lecithin.

6. The method of claim 1 , wherein the formulation has soya lecithin, isopropyl palmitate, steric acid, glycerin monostearate, isopropyl myristate, and polyoxyl 40 stearate.

7. The method of claim 1 , wherein the formulation is in the form of a gel.

8. The method of claim 6 , wherein the formulation is in the form of a gel.

9. The method of claim 1 , wherein said pain in the subject is pain associated with an inflammatory arthropathy.

10. The method of claim 4 , wherein said pain in the subject is pain associated with an inflammatory arthropathy.

11. The method of claim 8 , wherein said pain in the subject is pain associated with an inflammatory arthropathy.

12. The method of claim 1 , wherein said pain in the subject is pain associated with rheumatoid arthritis.

13. The method of claim 4 , wherein said pain in the subject is pain associated with rheumatoid arthritis.

14. The method of claim 8 , wherein said pain in the subject is pain associated with rheumatoid arthritis.

15. A method for the treatment of pain in a subject, wherein the pain is selected from the group consisting of joint pain, surface somatic pain, and pain associated with an inflammatory arthropathy, bursitis, a tendinopathy, psoriasis, or muscle stiffness, the method consisting of administering to the skin at or adjacent to the site in need of treatment an effective amount of a formulation consisting of i) lecithin, ii) optionally one or two penetration enhancer fatty acid ester compounds, and iii) an aqueous mixture of excipients to form a cream, gel, lotion, paste, suspension or dispersion for topical application to the skin of the subject; to thereby alleviate pain in the subject, said excipients being one or more of:
(a) cetyl alcohol,
(b) stearyl alcohol,
(c) glycerin monostearate,
(d) stearic acid,
(e) polyoxyl 40 stearate,
(f) urea,
(g) imidurea,
(h) alkanols,
(i) preservatives,
(j) buffers, and
(k) collodial insoluble skin protectant.

16. The method of claim 15 , wherein one or two penetration enhancer fatty acid ester compounds are present in the formulation.

17. The method of claim 16 , wherein the formulation has one penetration enhancer fatty acid ester compound selected from the group consisting of isopropyl palmitate and isopropyl laurate.

18. The method of claim 17 , wherein the penetration enhancer fatty acid ester compound is isopropyl palmitate.

19. The method of claim 15 , wherein the formulation is in the form of a gel.

20. The method of claim 15 , wherein said pain in the subject is pain associated with an inflammatory arthropathy.

21. The method of claim 18 , wherein said pain in the subject is pain associated with an inflammatory arthropathy.

22. The method of claim 15 , wherein said pain in the subject is pain associated with rheumatoid arthritis.

23. The method of claim 1 , wherein the formulation has a preservative selected from the group consisting of methyl paraben and propyl paraben.

24. The method of claim 15 , wherein the formulation has a preservative selected from the group consisting of methyl paraben and propyl paraben.

Assignees

• Oronsky Bryan T
• Oronsky Neil C
• Oronsky Arnold L
• Epicentrx Inc

Inventors

• Oronsky Bryan T
• Oronsky Neil C
• Oronsky Arnold L

Classifications

• A61P29/00

  Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] · CPC title

• A61P29/02

  without antiinflammatory effect · CPC title

• A61P25/00

  Drugs for disorders of the nervous system · CPC title

• A61P25/04

  Centrally acting analgesics, e.g. opioids · CPC title

• A61P3/04

  Anorexiants; Antiobesity agents · CPC title